Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03740594
Other study ID # Effect of KMC on neurobehavior
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 1, 2016
Est. completion date February 1, 2018

Study information

Verified date November 2018
Source Ain Shams University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This prospective cohort study was conducted on stable preterm infants (31 to 35 weeks gestation). Neonates were subjected to either daily KMC for 60 minutes, daily KMC for 120 minutes or conventional care (controls) for at least 7 days. Neonates were evaluated by Neonatal Intensive Care Unit Network Neurobehavioral Scale (NNNS) at 36 weeks gestation. Salivary cortisol was measured before and after first KMC session and after 7 days.


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date February 1, 2018
Est. primary completion date December 1, 2017
Accepts healthy volunteers No
Gender All
Age group N/A to 28 Days
Eligibility Inclusion Criteria:

- Stable preterm neonates with gestational age between 31 and 35 weeks.

Exclusion Criteria:

- Neonates with major congenital birth defects or chromosomal anomalies.

- Perinatal asphyxia and intra-ventricular hemorrhage.

- Hemodynamically significant cardiac abnormalities.

- Neonates received postnatal steroids.

- Neonates whose mothers had a history of drug abuse during pregnancy.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
KMC
Neonates were subjected to either daily KMC for 60 minutes, daily KMC for 120 minutes or conventional care (controls) for at least 7 days.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Ain Shams University

Outcome

Type Measure Description Time frame Safety issue
Primary Neonatal Intensive Care Unit Network Neurobehavioral Scale (NNNS) applying Neonatal Intensive Care Unit Network Neurobehavioral Scale (NNNS) which is used to assess the neuro-behavioral performance of neonates.It consists of 13 subscales :Habituation, Attention, Arousal, Regulation, Handling procedures, Quality of movement, Excitability, Lethargy, Non-optimal reflexes, Asymmetric reflexes, Hypertonicity, and Stress/abstinence scale.Scores of subscales are from 1 to 9. the age of 36 weeks
Primary Neonatal Intensive Care Unit Network Neurobehavioral Scale (NNNS) applying Neonatal Intensive Care Unit Network Neurobehavioral Scale (NNNS) which is used to assess the neuro-behavioral performance of neonates.It consists of 13 subscales :Habituation, Attention, Arousal, Regulation, Handling procedures, Quality of movement, Excitability, Lethargy, Non-optimal reflexes, Asymmetric reflexes, Hypertonicity, and Stress/abstinence scale.Scores of subscales are from 1 to 9. For stress, lethargy, non-optimal response and asymmetic reflexes, the higher the seb-scale, the worse. In other sub-scales, the higher the scale, the better. the age of 36 weeks
Secondary Salivary cortisol measuring salivary cortisol 7 days
See also
  Status Clinical Trial Phase
Withdrawn NCT01497509 - Intrapartum Epidural Fentanyl and Breastfeeding in the Immediate Postpartum Period: a Randomized, Controlled, Double-blinded Study N/A